Targeted Testing For Pancreatic Cancer: Avantect Vs. Multi-Cancer Tests

The realm of cancer detection has seen notable advancements, with tests designed to detect a myriad of cancers and those precision-engineered for specific ones. A question then emerges: for a condition as critical as pancreatic cancer, should one lean towards a multi-cancer detection test like Grail’s Galleri or a targeted test like Avantect? Here’s why we advocate the latter.